Improving Primary Care After Stroke (IPCAS) trial: protocol of a randomised controlled trial to evaluate a novel model of care for stroke survivors living in the community.
IPCAS investigator team,
MetadataShow full item record
Mullis, R., Aquino, R., Dawson, S., Johnson, V., Jowett, S., Kreit, L., Mant, J., & et al. (2019). Improving Primary Care After Stroke (IPCAS) trial: protocol of a randomised controlled trial to evaluate a novel model of care for stroke survivors living in the community.. BMJ Open, 9 (8. e030285)https://doi.org/10.1136/bmjopen-2019-030285
INTRODUCTION: Survival after stroke is improving, leading to increased demand on primary care and community services to meet the long-term care needs of people living with stroke. No formal primary care-based holistic model of care with clinical trial evidence exists to support stroke survivors living in the community, and stroke survivors report that many of their needs are not being met. We have developed a multifactorial primary care model to address these longer term needs. We aim to evaluate the clinical and cost-effectiveness of this new model of primary care for stroke survivors compared with standard care. METHODS AND ANALYSIS: Improving Primary Care After Stroke (IPCAS) is a two-arm cluster-randomised controlled trial with general practice as the unit of randomisation. People on the stroke registers of general practices will be invited to participate. One arm will receive the IPCAS model of care including a structured review using a checklist; a self-management programme; enhanced communication pathways between primary care and specialist services; and direct point of contact for patients. The other arm will receive usual care. We aim to recruit 920 people with stroke registered with 46 general practices. The primary endpoint is two subscales (emotion and handicap) of the Stroke Impact Scale (SIS) as coprimary outcomes at 12 months (adjusted for baseline). Secondary outcomes include: SIS Short Form, EuroQol EQ-5D-5L, ICEpop CAPability measure for Adults, Southampton Stroke Self-management Questionnaire, Health Literacy Questionnaire and medication use. Cost-effectiveness of the new model will be determined in a within-trial economic evaluation. ETHICS AND DISSEMINATION: Favourable ethical opinion was gained from Yorkshire and the Humber-Bradford Leeds NHS Research Ethics Committee. Approval to start was given by the Health Research Authority prior to recruitment of participants at any NHS site. Data will be presented at national and international conferences and published in peer-reviewed journals. Patient and public involvement helped develop the dissemination plan. TRIAL REGISTRATION NUMBER: NCT03353519.
IPCAS, MLAS, primary care, self-management, stroke
This study was funded by the National Institute for Health Research’s Programme Grant for Applied Research titled ‘Developing primary care services for stroke survivors’ reference PTC-RP-PG-0213 20001. The chief investigator for the study is JM, University of Cambridge email: firstname.lastname@example.org. The IPCAS trial is cosponsored by the University of Cambridge and NHS Cambridgeshire and Peterborough Clinical Commissioning Group. This research is covered by the Cambridge University's Public Liability and Professional Indemnity policy.
National Institute for Health Research (NIHR) (via Cambridgeshire and Peterborough Clinical Commissioning Group (CCG)) (PTC-RP-PG-0213-20001)
Embargo Lift Date
External DOI: https://doi.org/10.1136/bmjopen-2019-030285
This record's URL: https://www.repository.cam.ac.uk/handle/1810/294424
All rights reserved